← SynDRA
TOLEBRUTINIB
SynDRA canonical compound SYN0040153 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | BTK |
| Mechanism of action | bruton's tyrosine kinase (btk) inhibitor |
| Indication | multiple sclerosis |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
- BTK INHIBITOR
- Tyrosine-protein kinase BTK inhibitor
- bruton's tyrosine kinase (btk) inhibitor
Cross-references
Synonyms
- SAR442168
- PRN-2246
- PRN2246
- SAR-442168
- (R)-1-(1-Acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-imidazo[4,5-c]pyridin-2(3H)-one
- 2H-Imidazo(4,5-C)pyridin-2-one, 4-amino-1,3-dihydro-1-((3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl)-3-(4-phenoxyphenyl)-
- 4-Amino-1,3-dihydro-1-((3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl)-3-(4-phenoxyphenyl)-2H-imidazo(4,5-C)pyridin-2-one
- 4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-(prop-2-
- 4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-(prop-2-enoyl)piperidin-3-yl]-1H,2H,3H-imidazo[4,5-c]pyridin-2-one
- 4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]imidazo[4,5-c]pyridin-2-one
- 8CZ82ZYY9X
- AKOS040759681
- BDBM50557487
- BTK'168
- c]pyridin-2-one
- CHEMBL4650323
- CS-0119132
- EN300-6498433
- enoyl)piperidin-3-yl]-1,3-dihydro-2H-imidazo[4,5-
- EX-A4699
- example 3 [WO2016196840A1]
- GTPL10625
- HY-109192
- MS-28304
- SCHEMBL18285621
- Tolebrutinib [INN]
- Tolebrutinib [USAN:INN]
- Tolebrutinib [USAN]
- TOLEBRUTINIB [WHO-DD]
- UNII-8CZ82ZYY9X
- WHO 11268
- SAR 442168
- example 3 (WO2016196840A1)
- RefChem:190288
- BTK Inhibitor SAR442168
- Bruton's Tyrosine Kinase Inhibitor SAR442168
- C26H25N5O3
- Cenrifki
- Tolebrutinib?
Look up TOLEBRUTINIB in the interactive SynDRA portal →